Bristol-Myers SquibbBMY 
$49.49-1.00%24h
-1.00%24h
Global rank146
Market cap$100.70B
Change 7d2.57%
YTD Performance-3.81%
SP500 benchmarkUnderperform
P/E0
P/S2.24
Revenue$45.01B
Earnings$8.04B
Dividend yield4.7%
Main Sector
Healthcare
Bristol-Myers Squibb (BMY) Cash on Hand
BMY Cash on Hand in 2022: $12.28B
According to Bristol-Myers Squibb latest financial reports the cash on hand of BMY is $12.28B, an increase of 32.71% to 2022. At the end of 2022 company had $9.25B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
BMY Cash on Hand History from 2018 to 2023
-
Value:-
BMY Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $12.28B | 32.71% |
| 2022 | $9.25B | -46.27% |
| 2021 | $17.22B | 4.69% |
| 2020 | $16.45B | 6.87% |
| 2019 | $15.39B | 73.27% |
| 2018 | $8.88B | - |
View the Top Cash on Hand Companies 
